Genetic neurological channelopathies (original) (raw)

• Kullmann DM and Hanna MG (2002) Neurological disorders caused by inherited ion-channel mutations. Lancet Neurol 1: 157–166
  Article CAS Google Scholar
• Graves TD and Hanna MG (2005) Neurological channelopathies. Postgrad Med J 81: 20–32
  Article CAS Google Scholar
• Jiang et al. (2003) X-ray structure of a voltage dependant potassium channel. Nature 423: 33–48
  Article CAS Google Scholar
• Ptacek LJ et al. (1992) Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita. Neuron 8: 891–897
  Article CAS Google Scholar
• Fontaine B et al. (1990) Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene. Science 250: 1000–1002
  Article CAS Google Scholar
• Rojas CV et al. (1991) A Met-to-Val mutation in the skeletal muscle Na+ channel α-subunit in hyperkalaemic periodic paralysis. Nature 354: 387–389
  Article CAS Google Scholar
• Jurkat-Rott K et al. (1994) A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet 3: 1415–1419
  Article CAS Google Scholar
• Ptacek LJ et al. (1991) Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 67: 1021–1027
  Article CAS Google Scholar
• Ptacek LJ et al. (1994) Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis. Neurology 44: 1500–1503
  Article CAS Google Scholar
• Ptacek LJ et al. (1994) Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77: 863–868
  Article CAS Google Scholar
• Plaster NM et al. (2001) Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105: 511–519
  Article CAS Google Scholar
• Koch MC et al. (1992) The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 257: 797–800
  Article CAS Google Scholar
• Kubisch C et al. (1998) ClC-1 chloride channel mutations in myotonia congenita: variable penetrance of mutations shifting the voltage dependence. Hum Mol Genet 7: 1753–1760
  Article CAS Google Scholar
• Wu FF et al. (2002) Novel CLCN1 mutations with unique clinical and electrophysiological consequences. Brain 125: 2392–2407
  Article Google Scholar
• Bendahhou S et al. (1999) Activation and inactivation of the voltage-gated sodium channel: role of segment S5 revealed by a novel hyperkalaemic periodic paralysis mutation. J Neurosci 19: 4762–4771
  Article CAS Google Scholar
• Hayward LJ et al. (1999) Defective slow inactivation of sodium channels contributes to familial periodic paralysis. Neurology 52: 1447–1453
  Article CAS Google Scholar
• Lehmann-Horn F et al. (1987) Adynamia episodica hereditaria with myotonia: a non-inactivating sodium current and the effect of extracellular pH. Muscle Nerve 10: 363–374
  Article CAS Google Scholar
• Hanna MG et al. (1998) Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A). J Neurol Neurosurg Psychiatry 65: 248–250
  Article CAS Google Scholar
• Hoskins B et al. (1975) Hyperkalemic periodic paralysis: effects of potassium, exercise, glucose, and acetazolamide on blood chemistry. Arch Neurol 32: 519–523
  Article CAS Google Scholar
• Davies NP et al. (2000) Clinical, electrophysiological, and molecular genetic studies in a new family with paramyotonia congenita. J Neurol Neurosurg Psychiatry 68: 504–507
  Article CAS Google Scholar
• Weckbecker K et al. (2000) Different effects of mexiletine on two mutant sodium channels causing paramyotonia congenita and hyperkalemic periodic paralysis. Neuromuscul Disord 10: 31–39
  Article CAS Google Scholar
• Ricker K et al. (1994) Myotonia fluctuans: a third type of muscle sodium channel disease. Arch Neurol 51: 1095–1102
  Article CAS Google Scholar
• Cannon SC (1996) Sodium channel defects in myotonia and periodic paralysis. Ann Rev Neurosci 19: 141–164
  Article CAS Google Scholar
• Bulman DE et al. (1999) A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology 53: 1932–1936
  Article CAS Google Scholar
• Davies NP et al. (2001) Sodium channel gene mutations in hypokalemic periodic paralysis: an uncommon cause in the UK. Neurology 57: 1323–1325
  Article CAS Google Scholar
• Sternberg D et al. (2001) Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain 124: 1091–1099
  Article CAS Google Scholar
• Jurkat-Rott K et al. (2000) Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci USA 97: 9549–9554
  Article CAS Google Scholar
• Elbaz A et al. (1995) Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families. Am J Hum Genet 56: 374–378
  Article CAS Google Scholar
• Chinnery PF et al. (2002) Normokalemic periodic paralysis revisited: does it exist? Ann Neurol 52: 251–252
  Article Google Scholar
• Vicart S et al. (2004) New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis. Neurology 63: 2120–2127
  Article CAS Google Scholar
• Sansone V et al. (1997) Andersen's syndrome: a distinct periodic paralysis. Ann Neurol 42: 305–312
  Article CAS Google Scholar
• Davies NP et al. (2005) Andersen Tawil syndrome: new potassium channel mutations and possible phenotypic variation. Neurology 65: 1083–1089
  Article CAS Google Scholar
• Tristani-Firouzi M et al. (2002) Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 110: 381–388
  Article CAS Google Scholar
• Junker J et al. (2002) Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome. Neurology 59: 466
  Article CAS Google Scholar
• Dutzler R et al. (2002) X-ray structure of a CIC chloride channel at 3.0 Å reveals the molecular basis of ion selectivity. Nature 415: 287–294
  Article CAS Google Scholar
• Charlet-B N et al. (2002) Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 10: 45–53
  Article CAS Google Scholar
• Fournier E et al. (2004) Electromyography guides toward subgroups of mutations in muscle channelopathies. Ann Neurol 56: 650–661
  Article CAS Google Scholar
• Mulley JC et al. (2005) Susceptibility genes for complex epilepsy. Hum Mol Genet 14 (Suppl 2): SR243–SR249
  Article Google Scholar
• Alekov A et al. (2001) Enhanced inactivation and acceleration of activation of the sodium channel associated with epilepsy in man. Eur J Neurosci 13: 2171–2176
  Article CAS Google Scholar
• Claes L et al. (2001) De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 68: 1327–1332
  Article CAS Google Scholar
• Escayg A et al. (2002) Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 24: 343–345
  Article Google Scholar
• Wallace RH et al. (1998) Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel β1 subunit gene SCN1B. Nat Genet 19: 366–370
  Article CAS Google Scholar
• Biervert C et al. (1998) A potassium channel mutation in neonatal human epilepsy. Science 279: 403–406
  Article CAS Google Scholar
• Charlier C et al. (1998) A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 18: 53–55
  Article CAS Google Scholar
• Singh NA et al. (1998) A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 18: 25–29
  Article CAS Google Scholar
• De Fusco M et al. (2000) The nicotinic receptor β2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 26: 275–276
  Article CAS Google Scholar
• Steinlein OK et al. (1995) A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 11: 201–203
  Article CAS Google Scholar
• Haug K et al. (2003) Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat Genet 33: 527–532
  Article CAS Google Scholar
• Zuberi SM et al. (1999) A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 122: 817–825
  Article Google Scholar
• Jouvenceau et al. (2001) Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 358: 801–807
  Article CAS Google Scholar
• Sugawara T et al. (2001) A missense mutation of the Na+ channel αII subunit gene NaV1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci USA 98: 6384–6389
  Article CAS Google Scholar
• Sugawara T et al. (2002) Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology 58: 1122–1124
  Article CAS Google Scholar
• Meisler MH and Kearney JA (2005) Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest 115: 2010–2017
  Article CAS Google Scholar
• Browne DL et al. (1994) Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 8: 136–140
  Article CAS Google Scholar
• Adelman JP et al. (1995) Episodic ataxia results from voltage-dependent potassium channels with altered functions. Neuron 15: 1449–1454
  Article CAS Google Scholar
• Rea R et al. (2002) Variable K+ channel subunit dysfunction in inherited mutations of KCNA1. J Physiol 538: 5–23
  Article CAS Google Scholar
• Herson PS (2003) et al. A mouse model of episodic ataxia type-1. Nat Neurosci 6: 378–383
  Article CAS Google Scholar
• Eunson LH et al. (2000) Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol 48: 647–656
  Article CAS Google Scholar
• Ophoff RA et al. (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87: 543–552
  Article CAS Google Scholar
• Imbrici P et al. (2004) Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain 127: 2682–2692
  Article Google Scholar
• Ducros A et al. (2001) The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 345: 17–24
  Article CAS Google Scholar
• De-Fusco M et al. (2003) Happloinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associates with familial hemiplegic migraine type 2. Nat Genet 33: 192–196
  Article CAS Google Scholar
• Dichgans M et al. (2005) Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366: 371–377
  Article CAS Google Scholar
• Tottene A et al. (2002) Familial hemiplegic migraine mutations increase Ca2+ influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc Natl Acad Sci USA 99: 13284–13289
  Article CAS Google Scholar
• Cao YQ et al. (2004) Presynaptic Ca2+ channels compete for channel type-preferring slots in altered neurotransmission arising from Ca2+ channelopathy. Neuron 43: 387–400
  Article CAS Google Scholar
• van den Maagdenberg AM et al. (2004) A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41: 701–710
  Article CAS Google Scholar